| Senior Specialist - Automation Engineer |
Sasayama |
Japan |
Operations |
|
Research & Development |
Lie 16, 2024 |
| 高级医药代表 |
Hechi (Guangxi Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 16, 2024 |
| Private Cloud, Service Delivery Manager |
Prague |
Czech Republic |
Operations |
CTS |
Technology Transformation |
Lie 17, 2024 |
| Specialist - Mobile Device Management (MDM) Engineer |
Prague |
Czech Republic |
Operations |
CTS |
Technology Transformation |
Lie 17, 2024 |
| ERP Assurance Senior Consultant |
Selangor |
Malaysia |
Operations |
CTS |
Audit & Finance |
Lie 17, 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
Lie 17, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| Sr Manager/Manager-Monitoring |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Lie 18, 2024 |
| Equipment Qualification Engineer |
East Hanover |
USA |
Development |
Innovative Medicines |
Technical Operations |
Lie 18, 2024 |
| Laboratory Asset Maintenance and Calibration Engineer |
East Hanover |
USA |
Development |
Innovative Medicines |
Technical Operations |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| Associate Sales Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| Senior Statistical Programmer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 18, 2024 |
| Senior Process Expert / Manufacturing Science and Technology |
İstanbul Kurtköy |
Turkey |
Operations |
Innovative Medicines |
Technical Operations |
Lie 19, 2024 |
| Process Expert / Manufacturing Science and Technology |
İstanbul Kurtköy |
Turkey |
Operations |
Innovative Medicines |
Technical Operations |
Lie 19, 2024 |
| Mechanical Engineering -Senior Executive |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Technical Operations |
Lie 19, 2024 |
| Associate Director, Access & Reimbursement RLT, Seattle, WA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Lie 19, 2024 |
| Buyer Indirect Procurement TechOps |
Prague |
Czech Republic |
Operations |
Innovative Medicines |
Procurement |
Lie 19, 2024 |
| Patent Paralegal |
Cambridge (USA) |
USA |
Legal |
Pharma Research |
Legal & Intellectual Property & Compl. |
Lie 19, 2024 |
| （高级）大区经理 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 19, 2024 |
| 高级医药代表 |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 21, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |
| Tax Specialist (m/w/d) |
Schaftenau |
Austria |
Finance |
CTS |
Audit & Finance |
Lie 22, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |
| External Materials Planner |
İstanbul Kurtköy |
Turkey |
Operations |
Innovative Medicines |
Technical Operations |
Lie 22, 2024 |
| Principal Scientist 2 - Preclinical Safety |
Hyderabad (Office) |
India |
Biomedical Research |
Pharma Research |
Research & Development |
Lie 22, 2024 |
| SAP Security Manager |
Prague |
Czech Republic |
Operations |
CTS |
Audit & Finance |
Lie 22, 2024 |
| Regional Sourcing Manager APAC-Indirect (Japanese Speaker) |
Selangor |
Malaysia |
Operations |
CTS |
Procurement |
Lie 22, 2024 |
| Junior Engineer - Conferencing (AR / VR platforms) |
Prague |
Czech Republic |
Operations |
CTS |
Technology Transformation |
Lie 22, 2024 |
| Validation Expert |
İstanbul Kurtköy |
Turkey |
Operations |
Innovative Medicines |
Technical Operations |
Lie 22, 2024 |
| Sr. Clinical Sciences Trial Leader (Multiple Positions) |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
Lie 22, 2024 |
| Process Engineer, Multidiscipline |
Remote Position (USA) |
USA |
Operations |
Innovative Medicines |
Technical Operations |
Lie 22, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |
| Senior Specialist DDIT OPS Mfg Site IT |
Sasayama |
Japan |
Operations |
CTS |
Information Technology |
Lie 22, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |
| Associate/Manager, MSL（Oncology） |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Lie 22, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Lie 22, 2024 |